Crossmark Global Holdings’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.56M Sell
3,852
-106
-3% -$43K 0.03% 496
2025
Q1
$1.97M Sell
3,958
-267
-6% -$133K 0.03% 424
2024
Q4
$2.2M Sell
4,225
-1,597
-27% -$831K 0.04% 380
2024
Q3
$3.6M Sell
5,822
-446
-7% -$276K 0.06% 286
2024
Q2
$3.47M Buy
6,268
+5
+0.1% +$2.77K 0.07% 291
2024
Q1
$3.64M Buy
6,263
+143
+2% +$83.1K 0.07% 281
2023
Q4
$3.25M Sell
6,120
-43
-0.7% -$22.8K 0.07% 298
2023
Q3
$3.06M Buy
6,163
+1,594
+35% +$791K 0.07% 291
2023
Q2
$2.57M Buy
4,569
+606
+15% +$340K 0.06% 349
2023
Q1
$2.28M Sell
3,963
-399
-9% -$230K 0.05% 369
2022
Q4
$2.4M Sell
4,362
-2,009
-32% -$1.11M 0.06% 348
2022
Q3
$3.23M Sell
6,371
-102
-2% -$51.7K 0.09% 249
2022
Q2
$3.52M Sell
6,473
-292
-4% -$159K 0.09% 250
2022
Q1
$4M Sell
6,765
-110
-2% -$65K 0.09% 244
2021
Q4
$4.59M Sell
6,875
-270
-4% -$180K 0.1% 216
2021
Q3
$4.08M Buy
7,145
+254
+4% +$145K 0.1% 224
2021
Q2
$3.48M Sell
6,891
-848
-11% -$428K 0.08% 254
2021
Q1
$3.53M Buy
7,739
+270
+4% +$123K 0.09% 240
2020
Q4
$3.48M Sell
7,469
-157
-2% -$73.1K 0.09% 253
2020
Q3
$3.37M Sell
7,626
-659
-8% -$291K 0.09% 230
2020
Q2
$3M Buy
8,285
+144
+2% +$52.2K 0.09% 253
2020
Q1
$2.31M Sell
8,141
-114
-1% -$32.3K 0.08% 257
2019
Q4
$2.68M Sell
8,255
-1
-0% -$325 0.07% 285
2019
Q3
$2.41M Sell
8,256
-1,857
-18% -$541K 0.07% 310
2019
Q2
$2.97M Sell
10,113
-83
-0.8% -$24.4K 0.08% 269
2019
Q1
$2.79M Sell
10,196
-387
-4% -$106K 0.08% 282
2018
Q4
$2.37M Buy
10,583
+464
+5% +$104K 0.07% 303
2018
Q3
$2.47M Sell
10,119
-146
-1% -$35.6K 0.06% 345
2018
Q2
$2.13M Buy
10,265
+259
+3% +$53.6K 0.06% 375
2018
Q1
$2.07M Sell
10,006
-478
-5% -$98.7K 0.05% 407
2017
Q4
$1.99M Buy
10,484
+180
+2% +$34.2K 0.05% 431
2017
Q3
$1.95M Buy
+10,304
New +$1.95M 0.05% 418
2016
Q3
$1.95M Buy
+10,304
New +$1.95M 0.05% 418